IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Intuitive Surgical
- Study ID
- NCT07346066
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Ureter Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- filricianine — DRUGIV injection of IS-001 filricianine with near infrared (NIR) imaging
Study Details
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation
Key Dates
- First listed
- Jan 16, 2026
- Start date
- May 14, 2026
- Status verified
- Aug 2026
- Primary completion
- Apr 30, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 146 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Other: IS-001 InjectionUreter visualization and delineation will be compared between white light (standard of care) and near-infrared (NIR) imaging mode after each of the two single intravenous injections of IS-001.
Primary Outcome Measure
Independent reader assessment of ureter visualization by 1-5 Likert visualization rating scale from 1 not visible, 2 questionably visible, 3 low visibility, 4 visible, 5 clearly visible. [ Time Frame: 10 minutes after first injection ]
Central Contacts
- Clinical Project Manager4085232100
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Babak Rad, MD (PRINCIPAL_INVESTIGATOR) |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | Haddon Pantel, MD (PRINCIPAL_INVESTIGATOR) |
| Orlando Health | Orlando | Florida | 32806 | Marco Ferrara, MD (PRINCIPAL_INVESTIGATOR) Antonio Caycedo, MD (SUB_INVESTIGATOR) |
| Mountain View Hospital | Las Vegas | Nevada | 89128 | Garrett Friedman, MD (PRINCIPAL_INVESTIGATOR) |
| The Ohio State Unversity | Columbus | Ohio | 43210 | Emily Huang, MD (PRINCIPAL_INVESTIGATOR) Philip Bauer, MD (SUB_INVESTIGATOR) |
| Kettering Health | Kettering | Ohio | 45429 | Clinical Research Coordinator 855-500-2873 Minia Hellan, MD (PRINCIPAL_INVESTIGATOR) |
| St David's North Austin Medical Center | Austin | Texas | 78758 | Thiru Lakshman, MD (PRINCIPAL_INVESTIGATOR) |
| HCA Houston Healthcare Medical Center | Houston | Texas | 77004 | Eric Haas, MD (PRINCIPAL_INVESTIGATOR) Jean-Paul LeFave, MD (SUB_INVESTIGATOR) |
| MultiCare Tacoma General Hospital | Tacoma | Washington | 98405 | Laila Rashidi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Newport Beach, CA
Related Studies
- Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral PatencyPHASE4 · Recruiting · Prove pharm · Albany, New York
- Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal ImpairmentPHASE4 · Recruiting · Prove pharm · Albany, New York
- Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic SurgeriesPHASE1 · Recruiting · MediBeacon · Kansas City, Missouri